NCT04897516 - Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions

Chagas Disease

Interventions

DRUG

Short regimen of benznidazole

Benznidazole, under the brand name Abarax (100 mg tablet), 300 mg divided into three daily doses (100 mg every 08 hours) for 2 weeks.

DRUG

Short treatment with benznidazole

Benznidazole, under the brand name Abarax (100 mg tablet), 300 mg divided into three daily doses (100 mg every 08 hours) for 4 weeks.

DRUG

Standard treatment with benznidazole

Benznidazole, 300 mg divided into three daily doses (100 mg every 08 hours), orally for 8 weeks

Trial Locations (6)

NOT_YET_RECRUITING

"Instituto Nacional de Parasitología Dr. Mario Fatala Chaben", Buenos Aires

RECRUITING

Fundación Huésped, Buenos Aires

RECRUITING

Hospital Francisco Javier Muñiz, Buenos Aires

NOT_YET_RECRUITING

Hospital Donación Francisco Santojanni, Buenos Aires

RECRUITING

"Instituto de Cardiología de Corrientes Juana Francisca Cabral", Corrientes

RECRUITING

Centro de Chagas y Patología Regional, Hospital Independencia, Santiago del Estero